Bone-protecting drugs cut the risks for fractures caused by metastatic prostate cancer treatments
Full article: https://meetings.asco.org/abstracts-presentations/196744
Skeletal problems, especially bone fractures, are common in patients with advanced prostate cancer. To prevent these, many guidelines recommend the use of bone-protecting agents during treatment. The importance of giving a bone-protecting agent when treating patients with metastatic castration-resistant prostate cancer and bone metastases was confirmed in early results of an ongoing phase III trial. (11/5/21)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- What medications are available to treat my type of prostate cancer?
- Has my prostate cancer spread to my bones?
- Is radium-223 therapy necessary for my type of cancer?
- Does my current treatment put me at risk for bone fractures?
- Would I benefit from taking supplemental medicines to help protect my bones?
- Should I consult with a healthcare provider who has expertise in managing bone health for cancer patients?
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.